Polarean (@polareanimaging) 's Twitter Profile
Polarean

@polareanimaging

A leader in the field of lung imaging. Polarean (AIM: POLX) has successfully developed the first and only FDA approved hyperpolarized MRI contrast agent.

ID: 1220222620366446592

linkhttp://www.polarean.com calendar_today23-01-2020 05:52:06

92 Tweet

677 Followers

77 Following

Polarean (@polareanimaging) 's Twitter Profile Photo

🌬️ Today, May 6th, is #WorldAsthmaDay, and May is #AsthmaAndAllergyAwarenessMonth — an opportunity to recognize the millions affected by asthma and the innovations transforming their care. Asthma management is evolving. The advent of biologic therapies is enabling a

🌬️ Today, May 6th, is #WorldAsthmaDay, and May is #AsthmaAndAllergyAwarenessMonth — an opportunity to recognize the millions affected by asthma and the innovations transforming their care.  Asthma management is evolving.

The advent of biologic therapies is enabling a
Polarean (@polareanimaging) 's Twitter Profile Photo

We are excited to share that Alex Dusek, Chief Business Officer at Polarean, is attending the ATS 2025 Respiratory Innovation Summit (RIS) in San Francisco —joining innovators, investors, and industry leaders to explore the future of respiratory medicine. As part of the

We are excited to share that Alex Dusek, Chief Business Officer at Polarean, is attending the ATS 2025 Respiratory Innovation Summit (RIS) in San Francisco —joining innovators, investors, and industry leaders to explore the future of respiratory medicine. 

As part of the
Polarean (@polareanimaging) 's Twitter Profile Photo

Big News for Pulmonary Imaging & Pediatric Care 🚨 We’re proud to announce the next phase of our strategic partnership with Philips Healthcare — working together to expand access to advanced, radiation-free #XenonMRI for children with chronic obstructive lung diseases like asthma

Polarean (@polareanimaging) 's Twitter Profile Photo

Aloha, Hawaii — and mahalo to ISMRM 2025! With more than 6,000 attendees from around the world, this year’s meeting brought together the brightest minds in #MRI to share, learn, and collaborate. It was inspiring to see the continued momentum around #XenonMRI and the energy

Aloha, Hawaii — and mahalo to ISMRM 2025!

With more than 6,000 attendees from around the world, this year’s meeting brought together the brightest minds in #MRI to share, learn, and collaborate. It was inspiring to see the continued momentum around #XenonMRI and the energy
Polarean (@polareanimaging) 's Twitter Profile Photo

📣 We're headed to ATS 2025 in San Francisco! Polarean is proud to attend the American Thoracic Society (ATS) International Conference, the premier global event in pulmonary, critical care, and sleep medicine — kicking off this weekend in San Francisco. We’re excited to connect with leaders in

📣 We're headed to ATS 2025 in San Francisco!

Polarean is proud to attend the <a href="/atscommunity/">American Thoracic Society (ATS)</a> International Conference, the premier global event in pulmonary, critical care, and sleep medicine — kicking off this weekend in San Francisco.

We’re excited to connect with leaders in
Polarean (@polareanimaging) 's Twitter Profile Photo

We’re here on Day 2 of the American Thoracic Society (ATS) International Conference #ATS2025, and #XenonMRI is already making waves. 🌊 With over 30 posters and presentations featured this year, Xenon MRI continues to push the boundaries of pulmonary imaging innovation — from established diseases

We’re here on Day 2 of the <a href="/atscommunity/">American Thoracic Society (ATS)</a> International Conference #ATS2025, and #XenonMRI is already making waves. 🌊

With over 30 posters and presentations featured this year, Xenon MRI continues to push the boundaries of pulmonary imaging innovation — from established diseases
Polarean (@polareanimaging) 's Twitter Profile Photo

Great meeting with Tricha Shivas and Elise Hoover from the FSR and Prof. David Mummy from Duke Health at the American Thoracic Society (ATS) International Meeting (ATS2025). We had a meaningful discussion on how Xenon MRI could support real clinical solutions for sarcoidosis—helping

Great meeting with Tricha Shivas and Elise Hoover from the <a href="/StopSarcoidosis/">FSR</a> and Prof. David Mummy from <a href="/DukeHealth/">Duke Health</a> at the <a href="/atscommunity/">American Thoracic Society (ATS)</a> International Meeting (ATS2025).

We had a meaningful discussion on how Xenon MRI could support real clinical solutions for sarcoidosis—helping
Polarean (@polareanimaging) 's Twitter Profile Photo

Congratulations to our Chief Scientific Officer, Prof. Bastiaan Driehuys, on receiving the 2025 ATS Research Innovation and Translation Achievement Award from the American Thoracic Society (ATS)! 🏆 This prestigious honor celebrates his pioneering work translating Xenon MRI from the research

Congratulations to our Chief Scientific Officer, Prof. Bastiaan Driehuys, on receiving the 2025 ATS Research Innovation and Translation Achievement Award from the <a href="/atscommunity/">American Thoracic Society (ATS)</a>!  🏆 

This prestigious honor celebrates his pioneering work translating Xenon MRI from the research
Polarean (@polareanimaging) 's Twitter Profile Photo

Wrapping up a fantastic week at ATS 2025 in San Francisco! The Polarean team had a packed schedule—meeting with customers, prospective sites, and potential pharmaceutical partners, all exploring how Xenon MRI can help transform pulmonary care. There’s real momentum building

Wrapping up a fantastic week at ATS 2025 in San Francisco!

The Polarean team had a packed schedule—meeting with customers, prospective sites, and potential pharmaceutical partners, all exploring how Xenon MRI can help transform pulmonary care.

There’s real momentum building
Polarean (@polareanimaging) 's Twitter Profile Photo

As May comes to a close, we recognize Cystic Fibrosis (CF) Awareness Month — a time to honor the resilience of those living with CF and to spotlight the progress being made through science and innovation. At Polarean, we remain committed to pushing the boundaries of pulmonary

As May comes to a close, we recognize Cystic Fibrosis (CF) Awareness Month — a time to honor the resilience of those living with CF and to spotlight the progress being made through science and innovation.

At Polarean, we remain committed to pushing the boundaries of pulmonary
Polarean (@polareanimaging) 's Twitter Profile Photo

🚨 Breaking News: FDA expands XENOVIEW® indication to children ages 6 and older! 🚨 Polarean is excited to share that the FDA has approved our Supplemental New Drug Application to expand the use of XENOVIEW®. This approval immediately lowers the minimum patient age from 12 to 6

🚨 Breaking News: FDA expands XENOVIEW® indication to children ages 6 and older! 🚨

Polarean is excited to share that the FDA has approved our Supplemental New Drug Application to expand the use of XENOVIEW®. This approval immediately lowers the minimum patient age from 12 to 6
Polarean (@polareanimaging) 's Twitter Profile Photo

Polarean continues to strengthen its collaboration with Philips in advancing functional lung imaging, now with expanded potential for pediatric care. Dr. Iain Bruce, Senior Manager of Imaging and Applications at Polarean, and Dr. Matt Willmering of Cincinnati Children's recently

Polarean continues to strengthen its collaboration with <a href="/Philips/">Philips</a> in advancing functional lung imaging, now with expanded potential for pediatric care.

Dr. Iain Bruce, Senior Manager of Imaging and Applications at Polarean, and Dr. Matt Willmering of <a href="/CincyChildrens/">Cincinnati Children's</a> recently
Polarean (@polareanimaging) 's Twitter Profile Photo

Asthma and COPD care is evolving—are you ready for the next step? Biologic therapy in asthma and COPD is changing the way these diseases are managed. Join us for a live expert session: “Mucus Plugs and Functional Imaging: The Newest Biomarker Emerging in Asthma and COPD” 📅

Asthma and COPD care is evolving—are you ready for the next step?

Biologic therapy in asthma and COPD is changing the way these diseases are managed. 

Join us for a live expert session: “Mucus Plugs and Functional Imaging: The Newest Biomarker Emerging in Asthma and COPD”

đź“…
Polarean (@polareanimaging) 's Twitter Profile Photo

Spending time with our customers in the field is always rewarding! Recently, Dr. Kiarash Emami, our VP of Technology & Applications, visited the Xenon MRI research team at University of Oxford, led by Dr. Fergus Gleeson. Pictured here are Arjun Atreya (Radiopharmacy Technician, left)

Spending time with our customers in the field is always rewarding! Recently, Dr. Kiarash Emami, our VP of Technology &amp; Applications, visited the Xenon MRI research team at <a href="/UniofOxford/">University of Oxford</a>, led by Dr. Fergus Gleeson. 

Pictured here are Arjun Atreya (Radiopharmacy Technician, left)
Polarean (@polareanimaging) 's Twitter Profile Photo

🧬 The future of asthma and COPD care isn't just about symptoms—it's about seeing the underlying biology. On June 26, we're going beyond airflow and inflammation to explore one of the most promising developments in respiratory disease: mucus plugs as an imaging biomarker. 🧠

🧬 The future of asthma and COPD care isn't just about symptoms—it's about seeing the underlying biology.

On June 26, we're going beyond airflow and inflammation to explore one of the most promising developments in respiratory disease: mucus plugs as an imaging biomarker.

đź§ 
Polarean (@polareanimaging) 's Twitter Profile Photo

Happening tomorrow! Don’t miss your chance to join a breakthrough conversation on the future of asthma and COPD care. It’s not too late to register for our live expert webinar: “Mucus Plugs and Functional Imaging: The Newest Biomarker Emerging in Asthma and COPD” 📅 June 26 |

Happening tomorrow! Don’t miss your chance to join a breakthrough conversation on the future of asthma and COPD care.

It’s not too late to register for our live expert webinar: “Mucus Plugs and Functional Imaging: The Newest Biomarker Emerging in Asthma and COPD”

đź“… June 26 |
Polarean (@polareanimaging) 's Twitter Profile Photo

🌍 July 1 is #WorldBronchiectasisDay2025 – a day to raise awareness about bronchiectasis, a chronic lung disease that affects over 1 million people worldwide. Characterized by scarred and widened airways, it leads to mucus build-up, recurring infections, and a serious impact on

🌍 July 1 is #WorldBronchiectasisDay2025 – a day to raise awareness about bronchiectasis, a chronic lung disease that affects over 1 million people worldwide. Characterized by scarred and widened airways, it leads to mucus build-up, recurring infections, and a serious impact on
Polarean (@polareanimaging) 's Twitter Profile Photo

This Independence Day, we’re celebrating the power of perseverance—especially in the fight for better lung health. At Polarean, we’re proud to be advancing the future of respiratory care with our Xenon MRI platform, delivering noninvasive, radiation-free imaging that brings

This Independence Day, we’re celebrating the power of perseverance—especially in the fight for better lung health.

At Polarean, we’re proud to be advancing the future of respiratory care with our Xenon MRI platform, delivering noninvasive, radiation-free imaging that brings
Polarean (@polareanimaging) 's Twitter Profile Photo

Incredible clarity unlocked! 🚀 Check out these stunning images shared by one of our customers, showcasing how Philips Healthcare' new FDA-cleared SmartSpeed Precise AI reconstruction dramatically sharpens Xenon MRI scans. Whether in a healthy volunteer or a patient, the remarkable

Incredible clarity unlocked! 🚀

Check out these stunning images shared by one of our customers, showcasing how <a href="/PhilipsHealth/">Philips Healthcare</a>' new FDA-cleared SmartSpeed Precise AI reconstruction dramatically sharpens Xenon MRI scans. Whether in a healthy volunteer or a patient, the remarkable